Acute Illness & Injury Respiratory infections (viral & bacterial) Flu, COVID, strep, sinus infections Minor injuries & sprains Wound care & burns In-Office Therapeutics IM injections & IV treatments Nebulized breathing treatments Laceration repair & wound care Incision & drainage (I&D) Joint injections Diagnostics Rapid swabs (flu, COVID, strep) EKG Chest X-ray (CXR) Urinalysis (UA) STI testing Orthopedics Splinting & casting Joint reductions Nerve blocks Immediate imaging coordination Occupational Health Work-related injury care Return-to-work exams Pre-employment physicals Drug & alcohol testing DOT exams Fast Walk-In Care No appointment required Short wait times On-site testing & treatment Clear discharge instructions Onyx Medical Weight Loss & Wellness Weekly programs designed to support weight loss, energy, recovery, and hormone optimization with clinician supervision and clear follow-up

REDEFINE-1 (NCT05567796) is the first phase 3 clinical trial from this program to be completed [125]
With oral administration, only about nine percent of the drug is bioavailable but, with nasal administration, approximately 90 percent goes to work in the body
,
Diagnosis should include serum B12 levels interpreted in clinical context, full blood count, and where appropriate, intrinsic factor antibodies and parietal cell antibodies
Employer health benefits: coverage of GLP-1 medications